“…The bioanalytical component of a pharmacokinetic study requires a drug assay with simplicity, high sensitivity, selectivity, small volume requirements and rapid turnaround time. Only a few methods have been reported for the quantification of granisetron in biological fluids, which involves liquid chromatography (LC) with fluorescence detection (Boppana, 1995;Capacio et al, 1993;Cupissol et al, 1993;Huang et al, 1998Huang et al, , 1999Kudoh et al, 1994;Lazarus et al, 1999;Pinguet et al, Granisetron LC-ESI-MS/MS assay in human plasma 889 ORIGINAL RESEARCH 1996; Wada et al, 1998) and LC with tandem mass spectrometry (Boppana et al, 1996). In all the reported fluorescence detection methods, sensitivity was inadequate, chromatographic run time was longer, sample volume requirement was high and considered timeconsuming in sample preparation/extraction procedures.…”